|
 |
Vaccine Technology II
June 1-6, 2008 - Algarve, Portugal
| Editors: |
Barry C. Buckland, Merck & Co., Inc.
John G. Auniņš, Merck & Co., Inc.
Paula Marques Alves, ITQB/IBET
Kathrin U. Jansen, Wyeth Vaccine Research |
The articles for these proceedings are not peer-reviewed.
|
<Previous article
|
Next article>
|
Challenges and Solutions for the Next Generation of Vaccines: Development of Cell Culture-based Live Attenuated Influenza Vaccine
Jonathan Liu, MedImmune, Inc., USA
Luis Maranga, MedImmune, Inc., USA
Sachin Mani, MedImmune, Inc., USA
Richard Schwartz, MedImmune, Inc., USA
Jonathan Liu, Luis Maranga, Sachin Mani, and Richard Schwartz, "Challenges and Solutions for the Next Generation of Vaccines: Development of Cell Culture-based Live Attenuated Influenza Vaccine" in "Vaccine Technology II", Barry C. Buckland, Merck & Co., Inc.
John G. Auniņš, Merck & Co., Inc.
Paula Marques Alves, ITQB/IBET
Kathrin U. Jansen, Wyeth Vaccine Research
Eds, ECI
Symposium Series, Volume P09 (2008). http://services.bepress.com/eci/vaccine/6
|
|
|
|
 |
|
|
|
|
|
|
|
